We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.51B
1-Year Est. Return 25.86%
This Fund
S&P 500
This Quarter Est. Return
-2.55%
1 Year Est. Return
+25.86%
3 Year Est. Return
+100.08%
5 Year Est. Return
+137.58%
10 Year Est. Return
AUM
$1.51B
AUM Growth
-$1.12B
Cap. Flow
-$1.06B
Cap. Flow %
-70.31%
Top 10 Hldgs %
38.41%
Holding
452
New
24
Increased
51
Reduced
230
Closed
119

Sector Composition

1 Technology 20.75%
2 Healthcare 13.86%
3 Industrials 9.36%
4 Consumer Discretionary 8.46%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
101
Invesco QQQ Trust
QQQ
$466B
$2.17M 0.14%
3,762
+18
+0.5% +$10.9K
ETR icon
102
Entergy
ETR
$52.8B
$2.16M 0.14%
19,241
-72,302
-79% -$7.27M
PFE icon
103
Pfizer
PFE
$143B
$2.14M 0.14%
76,170
-220,786
-74% -$5.88M
MET icon
104
MetLife
MET
$60.5B
$2.09M 0.14%
29,607
-23,266
-44% -$1.74M
CORT icon
105
Corcept Therapeutics
CORT
$9.72B
$2.06M 0.14%
51,152
-14,742
-22% -$551K
CYTK icon
106
Cytokinetics
CYTK
$10.9B
$1.95M 0.13%
+29,588
New +$1.88M
UNH icon
107
UnitedHealth
UNH
$387B
$1.93M 0.13%
7,146
-22,278
-76% -$6.63M
FANG icon
108
Diamondback Energy
FANG
$55B
$1.91M 0.13%
9,679
-41,111
-81% -$6.99M
VZ icon
109
Verizon
VZ
$182B
$1.89M 0.13%
37,680
-195,589
-84% -$9.06M
FAST icon
110
Fastenal
FAST
$52.2B
$1.87M 0.12%
40,205
-10,274
-20% -$461K
TSN icon
111
Tyson Foods
TSN
$20.3B
$1.85M 0.12%
28,882
-100,135
-78% -$6.22M
LRCX icon
112
Lam Research
LRCX
$392B
$1.81M 0.12%
8,457
-54,027
-86% -$12.1M
FDX icon
113
FedEx
FDX
$74.7B
$1.79M 0.12%
5,029
-2,263
-31% -$786K
PVLA
114
Palvella Therapeutics
PVLA
$2.26B
$1.73M 0.11%
+13,839
New +$1.44M
PEP icon
115
PepsiCo
PEP
$187B
$1.72M 0.11%
11,076
-183
-2% -$28.5K
AMGN icon
116
Amgen
AMGN
$198B
$1.7M 0.11%
4,820
-12,472
-72% -$4.45M
VOO icon
117
Vanguard S&P 500 ETF
VOO
$974B
$1.69M 0.11%
2,833
-521
-16% -$326K
SBUX icon
118
Starbucks
SBUX
$120B
$1.68M 0.11%
18,768
+162
+0.9% +$15.3K
PWR icon
119
Quanta Services
PWR
$94.3B
$1.67M 0.11%
3,049
-15,180
-83% -$7.82M
CBLL
120
CeriBell Inc
CBLL
$710M
$1.62M 0.11%
88,354
-3,777
-4% -$75.9K
ITGR icon
121
Integer Holdings
ITGR
$3.24B
$1.59M 0.11%
18,112
-45,958
-72% -$3.91M
COLL icon
122
Collegium Pharmaceutical
COLL
$1.17B
$1.59M 0.11%
47,993
-2,056
-4% -$87K
BRK.B icon
123
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.58M 0.1%
3,291
+405
+14% +$199K
VLO icon
124
Valero Energy
VLO
$91.9B
$1.56M 0.1%
6,779
-5,858
-46% -$1.21M
SHEL icon
125
Shell
SHEL
$242B
$1.54M 0.1%
16,568
-15,001
-48% -$1.21M

Similar funds

F/M Investments's Q1 2026 Portfolio in Review

As of Q1 2026, F/M Investments held 452 positions worth $1.51B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

F/M Investments withdrew a net $1.06B in Q1 2026, closing 119 positions and reducing 230 holdings. Its most notable exit was Vanguard FTSE Emerging Markets ETF, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, F/M Investments opened a new position in Dimensional Core Fixed Income ETF worth $128M.

  • F/M Investments's largest Q1 2026 buy was Dimensional Core Fixed Income ETF: 3,036,000 shares worth $128M.
  • F/M Investments added most to Vanguard FTSE All-World ex-US ETF in Q1 2026, an estimated $46M increase.
  • F/M Investments's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $57.6M.
  • F/M Investments fully exited Vanguard FTSE Emerging Markets ETF in Q1 2026, selling an estimated $17.8M.
  • F/M Investments's ten largest holdings make up 38% of its $1.51B portfolio in Q1 2026.
  • F/M Investments opened 24 new positions and closed 119 in Q1 2026.
  • F/M Investments's portfolio value fell 43% quarter-over-quarter to $1.51B.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.